Loading clinical trials...
Loading clinical trials...
Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors: Phase II, Multicenter, Randomized, Controlled Clinical Trial
Conditions
Interventions
recombinant human endostatin adenovirus
Cisplatin injection
+1 more
Locations
4
China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Chongqing Cancer Hospital
Chongqing, China
Shanghai Ninth People's Hospital Affiliated Shanghai JiaoTong University School of Medicine
Shanghai, China
Start Date
October 1, 2014
Primary Completion Date
October 1, 2016
Completion Date
October 1, 2016
Last Updated
November 5, 2014
NCT06998069
NCT06912087
NCT06303180
NCT05418842
NCT03914378
NCT06003231
Lead Sponsor
Renmiao Zhang
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions